Today, Target Corp.® (NYSE:TGT) announced 42 new schools from across the country that will receive a new library as part of the 2011 Target School Library Makeover program. Education experts and advocates such as Alma Powell of the America’s Promise Alliance and Sir Ken Robinson, along with elected officials including Congressman John Kline, Chairman of the Education and the Workforce Committee and Congressman Gene Green (TX-29), were invited to celebrate this announcement with the principals at the Library of Congress. Additionally, principals from among the 42 elementary schools participated in a Principal Summit, led by Ralph Smith of The Annie E. Casey Foundation. The summit was designed to inspire school leaders, provide best practices for cultivating reading skills by using their new libraries, and explore how educators approach literacy strategies.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/target/50372/
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
New research from Nu Skin Enterprises, Inc. (NYSE:NUS) and its research partner LifeGen Technologies reveals specific anti-aging properties of Cordyceps sinensis (Cs-4), a mushroom traditionally believed to be an anti-aging herb in China. One investigati
Join the quest to save rock, as Activision Publishing, Inc.’s (Nasdaq: ATVI) highly-anticipated Guitar Hero®: Warriors of Rock hits store shelves nationwide today. Featuring the largest on-disc set-list ever in a Guitar Hero® game, Guitar Hero: Warriors of Rock’s furious finger-fretting rock music collection is headlined by some of the largest bands in rock and includes original tracks, re-records and bands making their Guitar Hero debut. With the all-new, rock inspired guitar controller, gamers will embark on an epic journey from the halls of punk music to the lava fields of rock treachery in the first ever Guitar Hero story-driven Quest Mode narrated by KISS front man Gene Simmons. Additionally, challenge hungry achievement junkies will find the game’s all-new Quickplay+ up to par as they strive to master the 13 star challenges packed into every one of the 90+ on-disc songs as well as every song in their Guitar Hero music library. Heightening the rock experience, the first album from Soundgarden in over 10 years, Telephantasm, will be bundled with one million Guitar Hero: Warriors of Rock launch units.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/guitarhero/46201/
Weight loss is perhaps the most common New Year’s resolution made and likely the most difficult to keep. Amway North America offers the NUTRILITE® Weight Management Program, which includes a genetic test that helps individuals find their genotype-matched diet, and offers weight management plans matched to that gene test’s results.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53285-amway-nutrilite-weight-management-program-new-year-resolutions-julie-upton
NASA Gene Kranz Admits Apollo is All 'Walt Disney Bullshit'.
This Video As You Hear & See it, From Disney Faking & Shaping The Memory
with NASA Public Domain Video in:
For All Mankind (1989)
NASA's Public Domain Movie:
Apollo 17 : On the Shoulders of Giants (1973)
NASA did redacted editing & cleaning up of the text, to cover what they really said in the written records of the Astronauts conversations.
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF 'FAIR USE' IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Apollo 17- Astronaut Gene Admits Apollo is 'Walt Disney Bullshit Moon Hoax'.
This Video As You Hear & See it, From Disney Faking & Shaping The Memory in:
In the Shadow of the Moon (2007).
NASA did redacted editing & cleaning up of the text, to cover what they really said in the written records of the Astronauts conversations.
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF FAIR USE IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Johnson & Johnson today honors the winners of the 2012 Dr. Paul Janssen Award for Biomedical Research in a ceremony and scientific symposium at the New York Academy of Sciences in New York, NY. Victor Ambros, Ph.D., of the University of Massachusetts Medical School, and Gary Ruvkun, Ph.D., of Massachusetts General Hospital and Harvard Medical School, received the award for their collaborative discovery of microRNAs (miRNAs) as central regulators of gene expression and development, and will share a $100,000 prize.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58019-johnson-and-johnson-jnj-2012-dr-paul-janssen-award-for-biomedical-research
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis.
The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
